एपीए उद्धरण

Archambault, B., Landi, D., & Schroeder, K. (2019). QOLP-34. DOSE FREQUENCY MODIFICATION OF TRAMETINIB TO MITIGATE SEVERE RASH AND IMPROVE QUALITY OF LIFE IN PEDIATRIC LOW-GRADE GLIOMA PATIENTS. Neuro Oncol.

शिकागो स्टाइल उद्धरण

Archambault, Bridget, Daniel Landi, और Kristin Schroeder. "QOLP-34. DOSE FREQUENCY MODIFICATION OF TRAMETINIB TO MITIGATE SEVERE RASH AND IMPROVE QUALITY OF LIFE IN PEDIATRIC LOW-GRADE GLIOMA PATIENTS." Neuro Oncol 2019.

एमएलए उद्धरण

Archambault, Bridget, Daniel Landi, और Kristin Schroeder. "QOLP-34. DOSE FREQUENCY MODIFICATION OF TRAMETINIB TO MITIGATE SEVERE RASH AND IMPROVE QUALITY OF LIFE IN PEDIATRIC LOW-GRADE GLIOMA PATIENTS." Neuro Oncol 2019.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.